Mobocertinib (TAK-788) in epidermal growth factor receptor gene (EGFR) exon 20 insertion mutation-positive (EGFRex20ins+) metastatic non-small cell lung cancer (mNSCLC): results from the platinum-pretreated patients (PPP) cohort of a phase 1/2 study Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Popat, Sanjay; Ramalingam, Suresh; Kim, Tae Min; Yang, James; Riely, Gregory; Mekhail, Tarek; Nguyen, Danny; Garcia Campelo, Maria Rosario; Felip, Enriqueta; Spira, Alexander; Piotrowska, Zofia; Bazhenova, Lyudmila; Vincent, Sylvie; Jin, Shu; Griffin, Celina; Diderichsen, Paul; Gupta, Neeraj; Bunn, Veronica; Lin, Jianchang; Lin, Huamao; Churchill, Eric; Mehta, Minal; Zhou, Caicun; Janne, Pasi

authors

Publication Date

  • March 1, 2022

webpage

published in

category

start page

  • S30

end page

  • S31

volume

  • 165